On GCEngine, we identify and engineer aaRS variants matched to an orthogonal tRNA decoder so that a reassigned codon (e.g., UAG) directs incorporation of a chosen ncAA with high efficiency and fidelity.This page describes an end-to-end aaRS library generation & screening service on GCEngine that follows the published E. coli - HEK293T workflow with quantitative readouts and mass-spectrometric confirmation (research use only; non-GMP).
aaRS libraries could be built on pyrrolysyl-tRNA synthetase (PylRS) backbones randomized at substrate-binding positions, alternative engineered TyrRS/LeuRS scaffolds are also supported when chemistry dictates. Screening in E. coli uses a staged survival cascade: positive selection via UAG-cat (chloramphenicol, +ncAA) followed by negative selection via UAG-barnase (−ncAA) to penalize background readthrough and canonical mischarging. Surviving clones are ranked by sfGFP-TAG fluorescence to quantify suppression efficiency and apparent fidelity (with counter-screens), then profiled by ncAA dose–response (EC50) and substrate permissivity. Top variants progress to HEK293T for parallel plate-reader verification and confirmation of site-specific incorporation by intact mass and LC–MS/MS, with optional misincorporation profiling.
Fig.1 Schematic for self-regulation by ncAA-dependent suppression of an amber stop codon within the aaRS. (Furuhata, Y., et al., 2024)
An end-to-end aaRS Library Generation & Screening program is provided on GCEngine—covering rational library design/build, bacterial positive/negative survival selection, quantitative fluorescent ranking (with dose–response/EC50 and permissivity), and cross-kingdom verification in mammalian cells with mass-spectrometric confirmation.
Library Design & Build (aaRS Variant Space)
Diversification is planned on a validated aaRS framework by randomizing substrate-binding positions, then assembled with the orthogonal tRNA and selection cassettes for E. coli screening. This setup follows published E. coli-mammalian workflows so discovered variants remain comparable across systems.
Primary Survival Selection in E. coli
Positive rescue of a chloramphenicol-TAG gene in +ncAA enriches synthetases that charge the orthogonal tRNA with the target ncAA, followed by barnase-TAG lethality in −ncAA to penalize canonical mischarging and leak. Plasmids from survivors are recovered for downstream fluorescent readouts and comparative evaluation.
Fluorescent Ranking, Dose–Response & Permissivity
An sfGFP-TAG reporter quantifies efficiency (+ncAA) and fidelity (−ncAA), after which uptake series establish working concentrations/ Dose–response (EC50) curves and reveal practical operating windows. Permissivity panels test whether single aaRS variants encode related ncAAs before cross-system transfer.
Cross-Kingdom Verification & MS Confirmation
Verification is mirrored in mammalian cells via plate-reader assays for efficiency, fidelity, and permissivity, aligning metrics with bacterial results. Purified ncAA-sfGFP is then analyzed by intact-LC–MS/MS, with spectra interpreted as Δmass relative to WT to confirm stable in-cell site-specific incorporation.
Ready to generate an aaRS library and down-select transfer-ready winners with quantitative proof? Contact us to outline your host, codon strategy, and target ncAA; a tailored plan with milestones and deliverables will be prepared.
All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.